Purchases and Sales Made in Q2 2023 in Candel Therapeutics, Inc. (CADL)
This table provides information about the institutional ownership of Candel Therapeutics, Inc. (CADL) during Q2 2023. The information is specifically focused on institutions that hold shares of Candel Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
BUY
|
- |
119KNew |
$142K - $211K
|
119K
$505K
|
|
|
Sep 21, 2023
Q2 2023
|
Baystate Wealth Management LLC
|
BUY
|
- |
101KNew |
$121K - $179K
|
101K
$428K
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
5.28K+ 11.34% |
$6.33K - $9.4K
|
51.8K
$221K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.69K+ 25.64% |
$2.02K - $3K
|
8.26K
$35.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
163New |
$196 - $290
|
163
$694
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 4.0% |
$4.8 - $7.12
|
104
$443
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-105- 0.08% |
$126 - $187
|
133K
$565K
|
|
|
Aug 01, 2023
Q2 2023
|
Empirical Asset Management, LLC
|
SELL
|
- |
-1K- 8.33% |
$1.2K - $1.78K
|
11K
$46.9K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-8.2K- 39.05% |
$9.84K - $14.6K
|
12.8K
$54.5K
|